These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31034911)

  • 1. Essential role of O-GlcNAcylation in stabilization of oncogenic factors.
    Makwana V; Ryan P; Patel B; Dukie SA; Rudrawar S
    Biochim Biophys Acta Gen Subj; 2019 Aug; 1863(8):1302-1317. PubMed ID: 31034911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross regulation between mTOR signaling and O-GlcNAcylation.
    Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
    J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
    Zhang N; Chen X
    Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
    Ma Z; Vocadlo DJ; Vosseller K
    J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway.
    Ferrer CM; Lynch TP; Sodi VL; Falcone JN; Schwab LP; Peacock DL; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cell; 2014 Jun; 54(5):820-31. PubMed ID: 24857547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.
    Ma Z; Vosseller K
    J Biol Chem; 2014 Dec; 289(50):34457-65. PubMed ID: 25336642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein O-GlcNAcylation and the regulation of energy homeostasis: lessons from knock-out mouse models.
    Issad T; Al-Mukh H; Bouaboud A; Pagesy P
    J Biomed Sci; 2022 Sep; 29(1):64. PubMed ID: 36058931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
    Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
    Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On a sugar high: Role of O-GlcNAcylation in cancer.
    Le Minh G; Esquea EM; Young RG; Huang J; Reginato MJ
    J Biol Chem; 2023 Nov; 299(11):105344. PubMed ID: 37838167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
    Nagel AK; Ball LE
    Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAcylation of the human epidermal growth factor receptor.
    Stateva SR; Villalobo A
    Org Biomol Chem; 2015 Aug; 13(30):8196-204. PubMed ID: 26108188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity.
    Le Minh G; Reginato MJ
    Adv Cancer Res; 2023; 157():195-228. PubMed ID: 36725109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New ELISA-based method for the detection of O-GlcNAc transferase activity in vitro.
    Qi J; Wang R; Zeng Y; Yu W; Gu Y
    Prep Biochem Biotechnol; 2017 Aug; 47(7):699-702. PubMed ID: 28296566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAc modification affects the ATM-mediated DNA damage response.
    Miura Y; Sakurai Y; Endo T
    Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAcylation affects β-catenin and E-cadherin expression, cell motility and tumorigenicity of colorectal cancer.
    Harosh-Davidovich SB; Khalaila I
    Exp Cell Res; 2018 Mar; 364(1):42-49. PubMed ID: 29391154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy.
    Xu C; Liu G; Liu X; Wang F
    Int J Mol Med; 2014 Mar; 33(3):624-32. PubMed ID: 24366041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of histones by sugar β-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated.
    Zhang S; Roche K; Nasheuer HP; Lowndes NF
    J Biol Chem; 2011 Oct; 286(43):37483-95. PubMed ID: 21896475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
    Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.